Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4.49 USD | -4.16% | -9.48% | +72.03% |
07/05 | Citigroup Starts Summit Therapeutics With Buy Rating, $7 Price Target | MT |
01/05 | Transcript : Summit Therapeutics Inc., Q1 2024 Earnings Call, May 01, 2024 |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationQuarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+72.03% | 3.29B | |
+7.52% | 111B | |
+11.38% | 106B | |
-12.64% | 22.24B | |
+0.44% | 21.25B | |
-4.18% | 18.97B | |
-37.85% | 18.52B | |
-8.58% | 16.81B | |
+37.41% | 12.54B | |
-23.95% | 8.09B |
- Stock Market
- Equities
- SMMT Stock
- News Summit Therapeutics Inc.
- Summit Therapeutics : HC Wainwright Downgrades Summit Therapeutics to Neutral from Buy